SCHEDULE: Armistice Capital Discloses INVO Fertility Stake

Armistice Capital, LLC and Steven Boyd have jointly filed a Schedule 13G, reporting beneficial ownership of 9.99% of INVO Fertility, Inc. common stock as of March 31, 2026.

Summary

• Armistice Capital, LLC and Steven Boyd have filed a Schedule 13G, indicating they collectively beneficially own 371,562 shares of INVO Fertility, Inc. common stock.
• This ownership stake represents 9.99% of the class of securities.
• The filing is an amendment to a previous filing, with the event date requiring this statement being March 31, 2026.
• Armistice Capital, LLC acts as the investment manager for Armistice Capital Master Fund Ltd., the direct holder of the shares.
• Steven Boyd is the managing member of Armistice Capital, LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not provide new operational or financial information about the company.

Positives

• Significant ownership stake of 9.99% indicates a substantial interest in INVO Fertility, Inc.

Negatives

• The filing does not contain specific financial performance data or operational updates for INVO Fertility, Inc., focusing solely on ownership disclosure.

Risks

• The filing does not explicitly mention any risks associated with INVO Fertility, Inc. or the reporting persons' investment.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding INVO Fertility, Inc.'s future performance.

Management Comments

• Armistice Capital, LLC, as the investment manager, exercises voting and investment power over the securities held by the Master Fund.
• Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities held by the Master Fund.
• The Master Fund disclaims beneficial ownership of the securities due to its Investment Management Agreement with Armistice Capital.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in publicly traded companies. This filing indicates Armistice Capital's strategic interest in INVO Fertility, Inc., a company operating in the fertility and assisted reproductive technology sector.

Stakeholder Impact

• Shareholders may view the increased stake by Armistice Capital as a sign of confidence or potential for future activism.
• Management of INVO Fertility, Inc. will be aware of the significant ownership held by Armistice Capital.

Next Steps

• Armistice Capital, LLC and Steven Boyd will continue to hold their beneficial ownership stake in INVO Fertility, Inc.
• Future amendments to this Schedule 13G will be filed if there are changes in beneficial ownership.

Key Dates

Keywords

INVO Fertility, Schedule 13G, Armistice Capital, Steven Boyd, beneficial ownership, common stock, SEC filing, investment management